Glyco-engineered Long Acting FGF21 Variant with Optimal...

Scientific Reports 2018 / 12 Vol. 8; Iss. 1

Glyco-engineered Long Acting FGF21 Variant with Optimal Pharmaceutical and Pharmacokinetic Properties to Enable Weekly to Twice Monthly Subcutaneous Dosing

Weng, Yan, Ishino, Tetsuya, Sievers, Annette, Talukdar, Saswata, Chabot, Jeffrey R., Tam, Amy, Duan, Weili, Kerns, Kelvin, Sousa, Eric, He, Tao, Logan, Alison, Lee, Darwin, Li, Dongmei, Zhou, Yingjian
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
8
Language:
english
Journal:
Scientific Reports
DOI:
10.1038/s41598-018-22456-w
Date:
December, 2018
File:
PDF, 5.04 MB
english, 2018
Conversion to is in progress
Conversion to is failed